GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Igene Biotechnology IGNE · USD

Materials · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Igene Biotechnology — daily IGNE Delayed
Market value
$15,378
Last close × shares
Volume
50.6k
Shares, 30 Oct 2026

About Igene Biotechnology

Its shares trade under the ticker IGNE. It has been listed since 29 July 1986. In the fiscal year to 31 December 2009, it reported revenue of $4.0m and a net loss of $140,747. At that date it held total assets of $4.8m and shareholders' equity of −$2.7m.

IGENE Biotechnology, Inc. engages in the research, development, production, and commercialization of specialty ingredients for human and animal nutrition. The company is headquartered in Columbia, Maryland. The firm develops, produces and markets specialty biochemical products. The company is a supplier of natural astaxanthin, a nutrient in different feed applications and a source of pigment for coloring farmed salmon species. Igene provides research and development services for microbial strain improvement and fermentation process development and scale up from shake flask, to pilot plant, to commercial sized fermentors. The company also provides analytical chemistry services for identification and quantization of carotenoids in foods, feeds, and animal tissues, including verification of wild versus farm raised salmonids. Within animal nutrition, the Company focus is to deliver astaxanthin to the fish feed market.

Figures and description from our data supplier, not checked against the company's own report.

More about Igene Biotechnology →

Latest on Igene Biotechnology

Our reporting

We have not reported on Igene Biotechnology yet.

Other Materials listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Igene Biotechnology's ticker?

Igene Biotechnology trades as IGNE on its US listing, under ISIN US4516951005.

What was Igene Biotechnology's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.